Let's look at cysts from both sides now (Q81894146)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18756294%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Let's look at cysts from both sides now (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18756294%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Seth L Alper

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18756294%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

language of work or name

English

0 references

publication date

1 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18756294%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18756294%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18756294%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18756294%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

699-702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18756294%20AND%20SRC:MED&resulttype=core&format=json

Autosomal dominant polycystic kidney disease

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Determinants of renal volume in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Epithelial transport in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Vasopressin directly regulates cyst growth in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

cDNA cloning and functional characterization of the mouse Ca2+-gated K+ channel, mIK1. Roles in regulatory volume decrease and erythroid differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

A human intermediate conductance calcium-activated potassium channel

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Modulators of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels and their Therapeutic Indications

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Gardos pathway to sickle cell therapies?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Abolition of Ca2+-mediated intestinal anion secretion and increased stool dehydration in mice lacking the intermediate conductance Ca2+-dependent K+ channel Kcnn4.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

The antifungal antibiotic, clotrimazole, inhibits Cl- secretion by polarized monolayers of human colonic epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Inhibition of intestinal Cl- secretion by clotrimazole: direct effect on basolateral membrane K+ channels

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021

Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.357

7 January 2021